The pulse oximeter market has witnessed significant growth over the past few years, driven by the increasing prevalence of respiratory and cardiovascular diseases, technological advancements, and the rising demand for remote patient monitoring.

The pulse oximeter market was valued at USD 2.34 billion in 2024 and is projected to grow from USD 2.46 billion in 2025 to USD 3.56 billion by 2032, registering a compound annual growth rate (CAGR) of 5.4% during the forecast period. North America dominated the market in 2024, accounting for a 40.63% share.

📌Top Companies in the Market

• GE HealthCare (U.S.)
• Masimo (U.S.)
• VYAIRE (U.S.)
• Nonin (U.S.)
• Medtronic (Ireland)
• Koninklijke Philips N.V. (Netherlands)
• Smiths Medical (ICU Medical Inc.) (U.S.)
• Beurer (Germany)
• NIHON KOHDEN CORPORATION (Japan)

📌 Key Trends in the Pulse Oximeter Market

1. Growing Demand for Remote Patient Monitoring

• Increased adoption of telehealth and home-based care is driving the use of pulse oximeters for real-time oxygen saturation tracking.
• Especially important for patients with respiratory conditions, post-COVID care, and chronic diseases like COPD or heart failure.

2. Rising Consumer Health Awareness

• More consumers are purchasing fingertip pulse oximeters for personal wellness tracking, especially during cold, flu, or allergy seasons.